Meningococcal Disease

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents [Phase 2]

  Phase 2 clinical trial update evaluating safety, tolerability, and immunogenicity of the MenABCWY vaccine administered on different dosing s…

• CLINICAL_TRIALS research · 2026-04-01
  Clinical Trial Update: Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years [Phase 3]

  A Phase 3 clinical trial evaluating Sinovac's Group ACYW135 meningococcal conjugate vaccine in children aged 2-6 years; the study is current…

• CLINICAL_TRIALS research · 2026-04-01
  Clinical Trial Update: Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months [Phase 3]

  Phase 3 study evaluating Group ACYW135 meningococcal conjugate vaccine in children aged 12-23 months; the trial is currently not yet recruit…

• CLINICAL_TRIALS research · 2026-04-01
  Clinical Trial Update: Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months [Phase 3]

  Phase III trial of a meningococcal conjugate vaccine (groups A, C, Y, W-135) in infants aged 3-5 months, status not yet recruiting.

• CLINICAL_TRIALS research · 2026-02-04
  Clinical Trial Update: Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate Vaccine

  An update on a clinical trial evaluating antibody persistence beyond five years after vaccination with MenFive (NmCV-5), a pentavalent menin…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-12-31
  Clinical Trial Update: Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine [Phase 1]

  This is a Phase 1 clinical trial evaluating an adsorbed, acellular pertussis vaccine component combined with Hib and ACWY meningococcal comp…

• CLINICAL_TRIALS research · 2025-12-29
  Clinical Trial Update: Assessment of Immunogenicity, Reactogenicity and Safety of the Drug GNG-DE in Comparison With the Reference Drug [Phase 3]

  Phase 3 clinical trial comparing immunogenicity, reactogenicity, and safety of GNG-DE versus a reference drug for meningococcal disease. The…

• CLINICAL_TRIALS research · 2025-12-01
  Clinical Trial Update: Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)

  An observational, passive surveillance study in the United States to collect information on pregnancies exposed to the MenQuadfi meningococc…

• CLINICAL_TRIALS research · 2017-11-27
  Clinical Trial Update: A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays [Phase 4]

  Phase 4 protocol to collect serum from healthy adults to serve as quality control samples for GlaxoSmithKline biological assays; the study s…

• CLINICAL_TRIALS research · 2016-09-29
  Clinical Trial Update: Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age [Phase 1, Phase 2]

  This clinical trial update reports on the immunogenicity and safety of a combined meningococcal A/C and Haemophilus influenzae type b conjug…